NCT01382706 2025-10-09
Docetaxel and Lapatinib in Metastatic Transitional Cell Carcinoma in Bladder
University of Southern California
Phase 2 Terminated
University of Southern California
Rainier Therapeutics
University of Michigan Rogel Cancer Center
M.D. Anderson Cancer Center